Accession Number: | 0001562180-20-000216 |
Date: | 2020-01-02 |
Issuer: | REGENXBIO INC. (RGNX) |
Original Submission Date: |
VASISTA VITTAL
C/O REGENXBIO INC.
9600 BLACKWELL ROAD, SUITE 210
ROCKVILLE, MD 20850
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 38.99 | 2020-01-02 | deemed execution date | A | 50,000 (a) | 2030-01-02 | common stock 50,000 | $38.99 | 50,000 | direct |
ID | footnote |
---|---|
f1 | 25% of the shares subject to this option shall vest after 12 months of continuous service with the issuer. the balance will vest in equal monthly installments over the 36 months following january 2, 2021 while the optionee provides continuous service to the issuer. |